Showing results (1131-1140 of 3,153) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 10, 2013
Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1Peter Matthew Kennedy de Blank, Jeffrey Ira Berman, Grant T Liu, et al.
Neuro-Oncology|May 10, 2013
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric gliomaZhigang Liu, Xiumei Zhao, Hua Mao, et al.
Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Neuro-Oncology|December 18, 2012
MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activityHongping Xia, Yukui Yan, Minghua Hu, et al.
Neuro-Oncology|January 22, 2013
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is gliomaMarkus Hutterer, Martha Nowosielski, Daniel Putzer, et al.
Neuro-Oncology|January 17, 2013
Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective studyKristin J Redmond, E Mark Mahone, Stephanie Terezakis, et al.
Neuro-Oncology|December 22, 2012
The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cellsTor-Christian Aase Johannessen, Lars Prestegarden, Amra Grudic, et al.
Neuro-Oncology|December 22, 2012
Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cellsKang Ho Kim, Ho Jun Seol, Eun Hee Kim, et al.
Neuro-Oncology|December 22, 2012
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targetsVera Miranda-Gonçalves, Mrinalini Honavar, Céline Pinheiro, et al.
Neuro-Oncology|December 25, 2012
On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cellsOwen D Stechishin, H Artee Luchman, Yibing Ruan, et al.
Pageof 316